Podcasts about kols

Jon Jordan and BlockchainGamer.biz editor Jenny Jordan talk through the week's news including:[1:04] Much anticipated mobile game FIFA Rivals is now live via app stores.[2:00] The game includes NFTs on the Mythos chain but doesn't mention blockchain or NFTs at all.[2:45] The gameplay is deeper than Jon thought - you're tapping on players and drawing lines to pass.[5:32 ]The metagame is about getting the best 11 players you can, levelling and training them up.[6:32] Players can only be used a certain number of times, before you have to pay to reup them.[7:10] This could be a way of mitigating the pay-to-win aspect of having powerful NFTs.[8:05] As well as real player NFTs, there are also real club kits - teams in the FIFA Club World Cup.[11:22] There is already a Messi NFT in the game. Very expensive.[12:21] Craft World's play-to-airdrop event for Dyno Coin - called Project Voyager - has gone live.[15:10] The top 25,000 players will get an airdrop. It looks like over 100,000 are now playing.[16:16] A key mechanic is increasing your multipler by spending in-game crystals and other tokens.[19:02] EVE Frontier has launched its new cycle and dropped its previous NDA.[23:51] EVE Frontier is building a valuable blockchain economy from the bottom-up.[26:01] CCP Games has spent a lot of time educating PC game journalists about blockchain.[29:43] Nexon's MapleStory N is another MMOG highlighting the value of blockchain.[30:30] Like CCP Games, Nexon wants to create an ecosystem in which thirdparties can build.[31:12] Its Henesys blockchain peaked at over 80,000 DAUWs this week. [31:52] The MSU marketplace has hit 1 million wallets and $13 million NFT trading volume.[35:28] Why are some KOLs critical of MapleStory N?[38:34] Does this change when we see the first $100,000 NFT in MapleStory N?

In this live episode from the LSI conference, Etienne Nichols sits down with Justin Bushko—known as the "MedTech Man" and author of Medical Device Fireside Chats—to dive into what separates thriving medical device companies from those that fail. From costly engineering missteps like ignoring tolerance stack-ups to the human factors issues that derail usability in the OR, Justin shares battle-tested advice based on his experience reviewing hundreds of device designs. He also delivers a wake-up call to startups overly focused on licensing or acquisition as the endgame. Whether you're an engineer, founder, or CEO, this episode offers critical insights into how to build a product that works—and a company that lasts.Key Timestamps00:00 – Introduction & Greenlight Guru Sponsor Message01:26 – Live from LSI: Introducing Justin Bushko02:55 – Why Early-Stage Engineering Mistakes Derail Companies04:12 – The Critical Role of DFM and Tolerance Analysis06:20 – Real-World Usability Failures: FDA Warning on Cranial Fixation Devices08:10 – Human Factors Oversights & Surgeon Behavior10:25 – What CEOs Should Focus On vs. Engineers12:20 – Economic Buyers, KOLs, and Commercialization Challenges14:05 – Don't Chase the Exit: Why Founders Should Build for Longevity16:00 – Final Thoughts and TakeawaysStandout Quotes“If your partners can't explain how and why they did your tolerance analysis, they probably didn't do it right—and it'll cost you nine months later.”—Justin Bushko, on the hidden dangers of relying too heavily on outsourced design partners.“Founders aiming for a quick exit send the wrong message. Build something sustainable. Acquisition should be a byproduct—not the goal.”—Justin Bushko, challenging the exit-first mindset common in early-stage MedTech.Top TakeawaysDFM & Tolerance Analysis Are Non-Negotiable: Skipping detailed design-for-manufacturing and tolerance stack analysis often leads to failure right before tooling and commercialization—when funds are already tight.Human Factors Must Be Built-In Early: Surgeons may not use your product as intended. Validate with a wide range of KOLs to uncover unintended use or misuse.Test for High-Risk Use Cases Early: For devices like inserters, test mechanical thresholds that could lead to field failures. Don't wait until post-market feedback.Understand Economic Buyers, Not Just KOLs: A surgeon's support doesn't guarantee adoption. You need champions who can advocate to hospital boards and procurement teams.Stop Chasing Exits—Build Real Companies: Investors and acquirers see through the “quick flip” mentality. A sustainable business model attracts more serious interest.ReferencesGreenlight Guru – Sponsor and end-to-end MedTech quality management platformJustin Bushko on LinkedInEtienne Nichols on LinkedInMedical Device Fireside Chats –

Dr Dean Berman is a performance and goal driven medical professional with over 15 years' extensive experience in the private, corporate and aesthetic healthcare sector. A detailed problem solver ranging from diagnosing andprescribing effective treatments to creating innovative training and education strategies to drive the growth of medical brands. Dr Berman is a clear and passionate communicator with the ability to forge long-term relationships with corporate stakeholders, KOLs and patients enabling keen uptake of projects and retention of specific desired direction.Dr. Maya Sinai is a Dermatologist and Mohs surgeon. Her love of dermatologic surgery and aesthetics started in her studies in medical illustration, where she earned a master's degree from John Hopkins University in Baltimore, MD.‍After illustrating a surgical atlas, Dr Maya graduated Medical School from Tel-Aviv University, NY Sackler program. Dr. Sinai completed two Mohs surgery fellowships and worked as a Mohs surgeon in Assuta, Soroka, and Shamirhospitals in Israel and Methodist Hospital in Houston, TX.For the past 10 years, Dr Sinai has worked in aesthetic, general, and surgical dermatology, offering innovativefacial rejuvenation, volume restoration, and anti-aging treatments. Dr Sinai is running her practice for aesthetics and surgical dermatology. These high achieving best friends support one another professionally and personally – Hanya Oversby enjoyed catching up with them recently to hear their amazing stories! For more information on Dr Dean Berman, please click on this linkhttps://www.linkedin.com/in/dr-dean-berman-md-797469242/?originalSubdomain=at For moreinformation on Dr Maya Sinai, please click on this linkhttps://www.hubmeded.com/experts/dr-maya-sinai  More informationabout Hanya Oversby can be found onhttps://hanyaoversby.com.au/

In this episode of The H-Files, Hakeem is joined by returning guest Spencer Jones to dive into the real-world applications of AI in building and scaling MedTech businesses.From cutting regulatory prep time in half to identifying top KOLs across Europe, Spencer walks through the exact tools and workflows he uses to supercharge productivity, speed, and innovation.

Summary   In this episode, Blockchain Wayne interviews Anna from Make, discussing her background in marketing and crypto, the importance of community building, effective marketing strategies, and the role of KOLs and influencers in the crypto space. They also delve into networking at events, preparing for conferences, and the significance of authentic connections in the industry.   Learn more about MAKE: https://www.makeagency.io/  Connect with Ana: https://t.me/Ana_MAKE_Global    Takeaways   Building a community is crucial before launching a project. Marketing is essential for project visibility and growth. KOLs and influencers play a significant role in crypto marketing. Authenticity and real connections are irreplaceable in marketing. Preparation is key for successful networking at events. Investing in marketing is necessary for long-term success. AI tools can enhance efficiency but cannot replace human touch. Understanding your budget is vital for effective marketing strategies. Networking at conferences can lead to valuable partnerships. Don't hesitate to approach people in the industry, regardless of their status.   Chapters   00:00 Introduction to Crypto and Marketing 03:01 The Importance of Community Building 05:59 Marketing Strategies in Crypto 09:03 The Role of KOLs and Influencers 11:56 Networking at Events 15:04 Preparing for Conferences 17:58 Final Thoughts and Advice

Vụ việc Quang Linh Vlogs và TikToker Hằng Du Mục bị khởi tố, bắt tạm giam vì hành vi lừa dối khách hàng được xem là hồi chuông cảnh tỉnh cho giới nghệ sĩ, KOLs đang tiếp tay cho nạn quảng cáo bẩn.

In this episode, our CEO, Jay Richards, sat down with Marit Tiesema, Senior KOL & Ambassador Specialist at Loop Earplugs, and Faustine Gambaretti, our French community member. They explore the relationship between brands, influencers, and KOLs, how Gen Z fact-checks online information, and the big question: Do we want authenticity or transparency from brands and influencers?Each episode wraps up with a debate on a trending topic. This week, we explored cultural influence and authenticity. Jorja Smith's new single sparked conversations on identity, while Bashy's return to music showed that relevance is about more than trends—it's about storytelling, resilience, and staying true to your roots.

In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, speaks with Caroline Ojaimi, PhD, Head of Global Scientific Communications, Congresses, and External Engagement at Takeda Oncology. Dr. Ojaimi shares her passion for Medical Affairs and provides insights into strategically redesigning organizational structures to enhance agility, efficiency, and cross-functional collaboration. Their discussion covers the importance of dedicated congress leadership, the role of external engagement in shaping scientific communications, and how integrated approaches drive better stakeholder interactions. A key focus of the conversation is the increasing emphasis on patient inclusion, highlighting initiatives such as patient-authored scientific publications and the role of Medical Affairs in ensuring patients have a voice in clinical research and education. As companies evolve to meet new industry trends, this episode offers practical strategies for creating synergies across Medical Affairs and strengthening its impact on HCPs, KOLs, and patients alike.

Deze week moeten we het natuurlijk hebben over de memecoin die gelinked werd aan Milei, de president van Argentinië. Wat op het eerste gezicht leek op een ordinaire pump and dump, bleek dat ook te zijn. Er was echter nog meer aan de hand. We praten je bij. Verder hebben we het over de bitcoin reserves van Amerikaanse Staten en is Bert door de 13f filings heen gegaan. We sluiten af met de marktupdate.Probeer Bitcoin Alpha 2 weken gratis!Satoshi Radio wordt mede mogelijk gemaakt door: Amdax, Watson Law, HVK Stevens en onze hoofdsponsor Bitvavo.Timestamps(00:00:00) Welkom en Podcast Introductie(00:12:00) Bookmark van Bert: Update over de bitcoin reserves(00:35:00) Bookmark van Bart: Libra(01:06:00) Bookmark van Bert: ETF's giving back: 150k naar bitcoin en 100k naar ethereum (Bitwise)(01:11:00) Bookmark van Bert: Coinbase Annual Report(01:21:00) Bookmark van Bert: “I dug through the 13F filings…”(01:39:00) Marktupdate(02:25:00) EindeBookmarksBert:Frontrunnen Amerikaanse staten de bitcoinreserve?“they could drive $23 billion in buying, or 247k BTC.”Bitcoin Reserve MonitorBitcoin Laws“If it can't pass Wyoming what chance does it have in Congress? ZEE-ro.”Samson Mow vs. CheckmateETF's giving back: 150k naar bitcoin en 100k naar ethereum (Bitwise)“I dug through the 13F filings…”Doorzoekbare 13F-bitcoin-databaseAnnual report CoinbaseBart:30 jan: Davis met Milei14 feb: Milei en z'n memecoin15 feb: I roundtripped bro15 feb: Libra team heeft $107 miljoen gecashed15 feb: Milei wist van niets16 feb: “addressing Libra”16 feb: Portnoy zegt dat hij er al vanaf wist16 feb: hebben KOLs allocatie gekregen?17 feb: buy bitcoin and stfu17 feb: Libra team zat ook achter Melania17 feb: Coffeezilla interview “we sniped our own coin”17 feb: van wie is die $100 miljoen?17 feb: Portnoy blijft coins shillen17 feb: Ben Chow verklaring18 feb: Threadguy doet zijn beklag18 feb: Milei: I didn't promote it, I shared it18 feb: I control him18 feb: Call Moty Povolotski (DefiTuna) and Ben Chow (Meteora decentralized exchange)19 feb: Milei TV interview goes wrong20 feb: Portnoy created $Greed en $Greed2Alexander Vinnik komt vrij als onderdeel van gevangenenruil RuslandAlexey Pertsev mag hoger beroep in “vrijheid” afwachtenHet verhaal van Tigran Gambaryan in NigeriaPlanB stapt over op ETF's

Argentine lawmakers have launched a movement to impeach President Javier Milei following a cryptocurrency-related controversy that led to the loss of millions of dollars from investors. Solana ecosystem is once again in the crosshairs of FUD.~This episode is sponsored by Tangem~Tangem ➜ https://bit.ly/TangemPBNUse Code: "PBN" for Additional Discounts!00:00 Intro00:16 Sponsor: Tangem00:54 Javier Milei denies $LIBRA02:30 Impeachment?03:10 JUP investigation04:44 KOLs coping + #istandwithJUP06:12 Solana is not all memes06:48 Toly needs better messaging07:43 "This time Solana is not coming back"08:52 Hester Pierce talks memecoins11:29 FTX will save the market?12:05 ETH vs SOL + ETH staking soon?13:06 SUI season incoming + Wen Walrus?14:44 Outro#Solana #Crypto #Bitcoin~Solana FUD Crashes Altcoins

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Gerit D. Mulder to the podcast!  Dr. Mulder gave Dr. Jensen an opportunity to join his practice at the Wound Healing Institute after residency, providing a tremendous foundation for future research that included the National Institutes of Health, and Department of Defense opportunities.  Dr. Mulder has a storied history in podiatric medical research in the wound care space.  He received his BS at University of Redlands; a masters degree from Cal State - San Bernadino, then received his DPM from the College of Podiatric Medicine. He received his PhD from Chulalongkorn University through University of California San Diego specializing in Biomedical Sciences/Stem Cells.  Gerit speaks 5 languages and has taught wound care, and implemented wound care programs around the world.  Tune in for a fabulous interview! Below is a brief history of Dr. Mulder's activities and qualifications: • Extensive expertise in the development, implementation and management of clinical trials, clinical operations and teams.  Experience as a lead Principal Investigator interacting with and guiding multicenter trials.  Direct interaction with the FDA, Pharmaceutical Industry and Academic Research Centers.  Focus on Inflammatory Diseases, Dermatology and Infectious Disease.  • Responsible for development and oversight than 120 clinical trials. • Supervised, educated, and guided research teams globally. • Developed project budgets, protocols, guidelines, and implementation plans for developing wound clinics. • Provided strategic and tactical input to the medical industry related to clinical trials with emphasis on Phase 1,2 and 3 studies.  • Created tissue and wound repair programs to increase product understanding to assist Emerging Markets. Additional Expertise and Affiliations Include: • Understanding of Regulatory Affairs. • International experience with monitoring and overseeing clinical trials. • Served as a national and international  • Provided input on new product development for novel disease states.  • Conversational skills in English, Spanish, Italian, French, and German • Extensive experience with KOLs and medical advisory boards. Physician at Christus St. Vincent Medical Center, Wound & Hyperbaric Center. December 2021 to current. • Provide advanced clinical care for chronic wounds of all etiologies including diabetic, venous, pressure, trauma and other wounds. • Direct wound and tissue repair and regeneration research Medical Research Consultant – Independent 2019 – current Clinical Tissue Repair and Regeneration Specialist – 2019-current • Consult internationally on Phase 1,2, and 3 clinical trials • Provide input for development and implementation of clinical trials and educational materials for health care providers related to phase 1, 2 and 3 studies as well as approved products. • Provide clinical care to patients with acute and chronic wounds of all etiologies Director, Professor of Surgery and Orthopedics University of California San Diego Medical Center, Wound Treatment and Research Center   April 1998- December 2013 •  Provided clinical and surgical care, conducted medical student, resident and staff education, oversaw clinical research.  Treated more than 3000 patients per year.  Published in peer reviewed medical journals and key presenter at medical conferences globally. • Oversaw research within my division of the Department of Trauma, with focus on tissue regeneration and repair, inflammatory and infectious related diseases and cell regeneration. June 1986-April 1998: President of WCI (Wound Consultants Inc., previously Wound Healing Institute)    WCI offered consulting services to the biotechnology and pharmaceutical industry related to clinical protocols and trials, implementation of related patient care, planning and managing medical education.  Advised on development of new products related to tissue regeneration and repair. Patient Care    Vice President of Marketing and Medical Affairs DermaRx  May 1995- March 1998 Vice President of Clinical and Regulatory Affairs Organogenesis, Inc.   May 1994-May 1995     Wound Clinic Director Veterans Administration Hospital Denver June 1983- Jne 1992 FDA Experience: • Participated as an advisor to the FDA and companies working with the FDA • Completed and submitted 510k for hydrogel, foam, and other wound treatment devices • Completed clinical section of PMA submission on Apligraf for Organogenesis • Consulted as wound care expert on panels for medical and pharmaceutical industry. • Chaired Human Subjects Committee in Denver for two years for a major IRB. • Interacted with FDA on Dermatology and Inflammatory Diesease Dr. Mulder can be reached at (619) 417-9249 or at gerit.mulder@gmail.com;  gerit.mulder@stvin.org  or on LinkedIn at http://www.linkedin.com/pub/gerit-mulder/a/321/6b5

In this episode of The Negotiation podcast, Todd Embley has a captivating conversation with Elyse Ribbons, a seasoned expert in the dynamics of influencer marketing in China. Elyse shares her extensive experience and insights into the unique landscape of social media and influencer engagement in China, highlighting the intricacies of platforms like RedNote (Xiaohongshu) and Douyin.The discussion opens with Elyse recounting her journey and how she became deeply involved with China, setting the stage for her dive into the digital marketing landscape there. She breaks down the major platforms used for influencer marketing, comparing them to their Western counterparts, and dives deep into the particularities of RED and Douyin, explaining their specific features and the demographics they appeal to.Elyse discusses the financial aspects of engaging with influencers, including the costs associated with different types of content creation, such as live streaming. She clarifies the distinctions between Key Opinion Leaders (KOLs) and Key Opinion Consumers (KOCs) and offers advice on how brands can select the right influencers to maximize the success of their marketing campaigns.Notably, Elyse touches on the latest trends in influencer marketing within China and provides her perspective on the future of international brands in the Chinese market amidst US-China tensions. This episode is a must-listen for anyone looking to understand the evolving dynamics of influencer marketing in China and how to navigate this complex but rewarding space effectively.Discussion Points:Elyse's personal journey and initial engagement with China.Detailed analysis of major Chinese platforms for influencer marketing.Specific features and demographics of RED and Douyin.Cost considerations in influencer engagements.Differences and impacts of KOLs versus KOCs.Strategies for selecting the right influencers for marketing campaigns.Emerging trends in the influencer marketing sector in China.Future outlook for international brands in the Chinese market.

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence. Today, in today's episode, Julia Steele Rodriguez joins us to discuss the critical role of Key Opinion Leaders (KOLs) in healthcare marketing. Julia, who led key teams in the breast and skeletal health division at Hologic, shares her vast experience in building and nurturing KOL programs across various med device companies. Throughout the episode, host Sara Payne and Julia discuss the intricacies of engaging KOLs effectively to enhance brand trust, communicate complex information, and foster both clinician and patient education. Together, they explore how to define what a KOL means within an organization, strategies for identifying and selecting the right KOLs, and the dynamics that make for a successful, long-term KOL partnership. Thank you for being part of the Health Marketing Collective, where strong leadership meets marketing excellence. The future of healthcare depends on it. Key Takeaways: Defining KOLs: Julia emphasizes the necessity of having a clear, shared definition of a KOL within an organization. Aligning on this definition ensures that everyone understands that KOLs are influential figures who can impact healthcare professionals and patients beyond their own organization. Identifying the Right KOLs: Strategies include researching publications, conferences, and professional societies to find those who are influential in their field. Julia stresses the importance of considering both objective data and subjective elements like personality and organizational fit. Fostering Long-Term Relationships: For KOL partnerships to be successful, they must be mutually beneficial. This involves understanding the KOLs' interests and ensuring they find value in the partnership, be it career development or influencing market innovations. Challenges in KOL Programs: Successful KOL partnerships require seamless internal processes, such as contracting and communication, as well as clear expectation setting and regular updates to maintain engagement and trust. Impact of KOLs on Marketing Strategy: Effective KOL partnerships can significantly influence healthcare marketing strategies, as evidenced by Hologic's success in advancing three-dimensional mammography as the standard of care. KOLs can powerfully advocate for policies, enhancing both market presence and healthcare access. This insightful conversation with Julia offers valuable perspectives on integrating KOLs into healthcare marketing efforts, underscoring their role in advancing organizational objectives and healthcare outcomes. [embed]https://youtu.be/oaAmR-Mk3zE[/embed]

The future belongs to those who embrace AI and cryptocurrencies—especially businesses looking to scale! Ignoring these innovations could mean missing the next wave of opportunity and productivity. In the latest episode of the Marketing Boost Solutions Podcast, host Marco Torres sits down with Abhishek Singh Rajpurohit, CEO of Voice of Crypto and the visionary behind Vitamin A, the world's first AI agents and KOLs marketplace. Together, they unravel the evolving landscape of cryptocurrency and artificial intelligence (AI), diving into how these disruptive technologies are reshaping business operations. From the rise of Bitcoin to the expansive world of decentralized finance, Abhishek shares expert insights on how crypto can streamline transactions, reduce costs, and unlock new opportunities for entrepreneurs worldwide. But the conversation doesn't stop there. Marco and Abhishek dive into the transformative power of AI agents—intelligent digital tools designed to enhance efficiency, automate processes, and revolutionize customer engagement. Abhishek simplifies complex concepts into actionable strategies, providing a roadmap for entrepreneurs eager to stay ahead in today's fast-paced digital world. Whether you're curious about Web3, the future of finance, or how AI can supercharge your marketing efforts, this episode is packed with valuable takeaways to fuel your business growth.

In this episode of Medsider Radio, we sat down with Brent Ness, President and CEO of Aclarion, a startup developing a decision-support tool designed to improve the diagnosis and treatment of chronic low back pain. Brent has over 28 years of experience in medtech. Before Aclarion, he led Cleerly as President & CCO, driving the adoption of their AI cardiology solution through strategic partnerships. As COO of Mighty Oak Medical, he guided their FIREFLY spine navigation platform from FDA clearance to international launch. At HeartFlow, Brent spearheaded the global expansion of their image-based SaaS solution, and at Medtronic, he led the acquisition and rollout of the O-Arm technology. His career also includes leadership roles at GE Healthcare, Philips North America, and ProNerve.In this interview, Brent shares his approach to reimbursement, why continuing to prove your technology is crucial (even after regulatory approval), and how to effectively engage with KOLs for optimal support.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Brent Ness. 

This memecoin could be set up for immense success in 2025. One of the most unique projects to launch on the most valuable blockchain in the world, Bitcoin, has a ton of tailwinds behind it. Fair launch, no VCs, no KOLs dumping on you, and the undisputed leader of memes on $BTC. Memes have been one of the best performing sectors in crypto, and this under-the-radar coin could become a leader.

Jon Jordan and BlockchainGamer.biz editor Jenny Jordan discuss all the news from 2024. [2:16] The success of Pixels was an ongoing trend in 2024; but it wasn't always about DAUWs. [2:35] Heroes of Mavia was the first big game and token launch of 2024 but it didn't scale. [4:10] In 2024, we saw a lot of blockchain games launching through app stores but no big hits. [6:10] Browser vs app stores and PC gaming stores remains a key business decision. [8:44] A lot of meme-y game coins such as MON, PORTAL, CARV, XAI launched in Q1. [11:30] There was a lot of news about chain migration - so many new L2 and L3 chains. [13:00] In Q2, there was a big change in sentiment with game token prices tanking. [14:11] The rise of KOLs, who encouraged retail crypto to invest in new tokens with often bad results. [16:05] The rise of Telegram and TON as a strong marketing channel for blockchain games. [17:46] Another nascent year for Immutable: Guild of Guardians was not a success. [22:17] But in Immutable's defence... 4 million Immutable Passport wallet sign-ups. [28:28] In Q3, the issue of bots became a problem esp. in respect to airdrops and token rewards. [30:09] What are you trying to do with your blockchain game when it comes to giving out value? [32:04] Does it matter if bots or AI agents are paying $10 to play your game? [32:30] The other thing in Q3 was the start of successful games on Ronin - Wild Forest, Lumiterra etc. [34:56] Pretty much every game launched on Ronin has got +100,000 DAUWs in testing. [37:19] Should we view console game Off The Grid as a success? [44:22] Whatever happened to The Sandbox? [45:25] CCP Game's EVE Frontier is now in closed alpha testing. [46:59] What's significant is these projects are very serious about the value of blockchain in games. [49:45] More generally, the US presidential election was the clear pivot point for crypto in 2024. [52:51] Investment into the sector was down on 2023 but around $1 billion.

In this episode of Web3 with Sam Kamani, Sam sits down with Vlad from EVAA Protocol, a leading DeFi lending platform on the TON ecosystem. Vlad shares his journey of building on TON since early 2023, insights into how EVAA scaled from a hackathon project to TON's primary lending protocol, and the unique challenges of bringing DeFi utility to the Telegram-based TON ecosystem. This conversation dives deep into the evolution of TON, the impact of the community's growth, and the future of TON's DeFi landscape. An insightful episode for developers, investors, and anyone interested in TON and its potential for decentralized finance. Key Timestamps [00:00:00] Introduction: Sam introduces Vlad from EVAA Protocol, TON's primary DeFi lending protocol, and outlines the focus of today's discussion. [00:01:30] Vlad's Background and Entry into TON: Vlad shares his journey from working in banking to building DeFi protocols on TON and his role in EVAA. [00:03:30] How EVAA Started: Vlad explains how EVAA began as a hackathon project, gaining traction and eventually support from TON Ventures and FriendsDAO. [00:05:30] Challenges in the TON Ecosystem: Vlad highlights the challenge of educating Telegram's non-Web3-native user base about DeFi. [00:07:00] TON's Growth and Ecosystem Shifts: Vlad shares how the TON ecosystem evolved with Telegram's support and millions of new users engaging with on-chain activities. [00:09:30] The Impact of Native Utility Tokens: Discussion on how native TON assets, like NotCoin, created new opportunities and grew EVAA's TVL. [00:12:00] Current Crypto and DeFi Trends: Vlad's observations on recent changes in the DeFi and crypto ecosystem and the growth of sustainable finance within TON. [00:15:00] Sustainable Utility for TON: How EVAA plans to leverage liquid staking, lending, and new projects like Athena to increase TON's DeFi utility. [00:17:30] Future Growth Opportunities: Vlad outlines the launch of TGBTC, layer zero integrations, and other milestones expected to bring liquidity to TON. [00:19:00] Upcoming Plans and Support Needed: Vlad shares EVAA's upcoming token launch, expected in Q1 2025, and their search for key opinion leaders (KOLs) to help promote it. [00:20:00] Closing Remarks: Sam concludes, sharing excitement for EVAA's progress and potential in the TON ecosystem, and future updates. Connect https://evaa.finance/ https://twitter.com/evaaprotocol https://www.linkedin.com/company/evaa-protocol https://twitter.com/vld_kms https://pt.linkedin.com/in/vlad-kamyshov-194a1b220 Disclaimer Nothing mentioned in this podcast is investment advice and please do your own research. Finally, it would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend.Be a guest on the podcast or contact us - https://www.web3pod.xyz/

This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.   This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery (dot) com.   In this episode, Jim discusses…  The role of the Thought Leader Liaison (TLL) and how it fits into an organization (as it relates to medical affairs and commercial)?  The strategic objectives for TLLs  How TLLs are evaluated (metrics or key performance indicators)  How TLLs collaborate with MSLs, and what are the most effective ways for these roles to work together to engage KOLs and other key stakeholders  What are the key skills, competencies and backgrounds that make for a successful TLL   The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.     MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #thoughtleaderliaison #careers

Influencers are NOT KOLs. We discuss using key opinion leaders (KOLs) and influencers in pharmaceutical and medical device marketing. Key Takeaways:- Influencers vs. KOLs: Influencers have large social media followings and can engage younger demographics, while KOLs are respected experts whose endorsements are based on scientific evidence.- Benefits and Risks: Influencers can create relatable content but risk non-compliance, while KOLs offer credibility but may deliver more conservative messages.Best Practices:  - Align with influencers and KOLs who match your target audience.  - Ensure understanding of regulatory requirements.  - Conduct thorough vetting and provide training.  - Establish clear contracts and monitor content for compliance. For Life Sciences Attorneys:It's vital to review contracts, monitor content, and collaborate with marketing teams to protect company interests.For more insights, subscribe to our podcast and reach out to the Kulkarni Law Firm for guidance on navigating influencer campaigns while minimizing legal risks.Support the show

This week's guest is Juan Daccach, MD, VP Global Product Safety at Merz Aesthetics who discusses Safety and its role in Medical/Product Safety and the interaction between safety physicians and medical affairs physicians (for both pharma and device)   This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery (dot) com.   In this episode, Juan shares…  The role of product safety in the biotech medical device industries, and how it fits with medical affairs  How  product safety differs in a pharma company vs a device company  The key challenges medical affairs professionals face when communicating safety information to healthcare providers (HCPs)  How MSLs might proactively engage with key opinion leaders (KOLs) regarding emerging safety data for a product What trends are emerging for MSLs and medical affairs as it relates to product or device safety.   The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.    MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions. #msl #medicalaffairs #medicalscienceliaison #MSLtalk #careers

Send us a textWondering what sets the stage for the next big altcoin surge? Join me, Joeri Billast, in an insightful conversation with Quinten François, a key thought leader in the crypto community. Together, we unravel the intricacies of the current reaccumulation phase dominated by Bitcoin and Ethereum ETFs, setting the scene for potential altcoin growth. Gain exclusive insights from Quinten as he highlights intriguing trends in the altcoin landscape, including AI, real-world assets, and the buzz surrounding decentralized physical infrastructure networks. We also cast a spotlight on the ever-evolving landscape of Web3 gaming, with Quinten sharing his journey and the transformative impact of KOL marketing in the crypto sphere since he became a full-time KOL in 2017.Amidst the noise of the crypto world, how do you ensure genuine engagement? Explore the challenges of authentic marketing strategies and the nuances of identifying fake interactions on platforms like Instagram and Twitter. Discover how WeRate is pioneering solutions to tackle fake reviews and review bombing through innovative technology. Lastly, we ponder the emergence of a "killer app" in the blockchain domain, particularly in gaming, while reflecting on how trends like the metaverse and AI transition from traditional tech realms into crypto. Don't miss these thought-provoking discussions and stay connected with me on X for the latest updates and insights into these ever-evolving technological landscapes.Looking to recharge and gain fresh insights into Web3 and AI? Check out the Sintra Synergies Retreat—an immersive 5-day experience in Portugal, designed for forward-thinking leaders like you. Learn more and secure your spot at sintrasynergies.com.

This week's guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success.   This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com   In this episode, Stephanie shares…  How might MSLs need to adapt their approach to engage with KOLs and healthcare providers in the future?  How the role of Medical Science Liaisons might evolve in the next 5 to 10 years  What emerging trends or Industry challenges will have the most significant impact on MSL roles  What new skills or competencies MSLs will need to develop in order to stay relevant as the field continues to evolve  How important digital literacy and familiarity with emerging technologies (such as AI or data analytics) will be for MSLs in the future   The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.    MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #MSLtalk #careers

Curious about what it takes to become a Key Opinion Leader (KOL) and why they matter in the biotech space? In this episode, hosts Elaine Hamm and James Zanewicz dive deep into the world of KOLs. Whether you're looking to connect with experts in specific fields or are interested in positioning yourself as a leader in a certain sector of biotech, this episode offers valuable insights on identifying, engaging, and maximizing the influence of key opinion leaders – or yourself AS one! Elaine and James share their personal experiences, covering everything from networking strategies to the importance of building genuine relationships. If you're ready to harness the expertise of KOLs and grow your brand or business, this is the episode for you! In this episode, you'll learn: What defines a Key Opinion Leader, and what is their role in shaping fields like science, medicine, and business? Practical strategies for identifying and approaching KOLs to enhance your startup or organization's credibility. Tips for positioning yourself as a KOL, from honing your niche to expanding your professional network. Tune in to discover how KOLs drive innovation and elevate industries! Links: Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine. Connect with Elaine Hamm, PhD. Connect with Key Opinion Leaders: Heddwen Brooks, PhD, Suresh Sikka, PhD, R. Shane Tubbs, PhD, Sarah Lindsey, PhD, Conor Grennan, MBA, Patrik Erlmann, PhD, Andrew Latham, PhD, Tari Suprapto, PhD, Kirsten Leute, MBA, Sarah Benson-Konforty, MD, and Marc Sedam, MBA. Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024. Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Gm! this week, we begin by discussing Snowden's recent comments that Solana is centralized. We then deep dive into Mert's biggest takeaways from recent conferences, the impact of Firedancer, reasons to be bullish DePin & more. Enjoy! -- Follow Mert: https://x.com/0xMert_ Follow Jack: https://x.com/whosknave Follow Lightspeed: https://twitter.com/Lightspeedpodhq Subscribe to the Lightspeed Newsletter: https://blockworks.co/newsletter/lightspeed -- DragonSwap is the DeFi Hub on Sei's Layer 1, allowing users to swap, provide liquidity, and farm! Built on Sei's sub-second execution environment, DragonSwap is transforming the DEX landscape by building an “onchain CEX” that leverages chain-abstracted AVSs, enabling users to buy any asset on any chain. With tons of incentives already available, September will bring even more to Sei users with partners like Stargate and Frax! Start farming on Sei today by visiting https://dragonswap.app/ -- (00:00) Introduction (03:28) Is Solana Centralized? (18:02) Defining Success In Crypto (23:49) Sei Ad (24:15) Firedancer (32:50) Solana TPS & Block Demand (39:37) The Firedancer Impact (44:49) Crypto's KOLs (53:09) Crypto Conferences (56:19) Bullish DePin -- Disclaimers: Lightspeed was kickstarted by a grant from the Solana Foundation. Nothing said on Lightspeed is a recommendation to buy or sell securities or tokens. This podcast is for informational purposes only, and any views expressed by anyone on the show are solely our opinions, not financial advice. Mert, Jack, and our guests may hold positions in the companies, funds, or projects discussed.

En oktoberdag i 2013 kommer ikke de to norsk-somaliske tenåringsjentene Ayan og Leila hjem til vanlig tid. Senere på kvelden kommer sjokkmeldingen: De er på vei til Syria. En desperat far prøver å finne dem.  Hvis du vil høre hele serien med en gang, kan du bli abonnent på Svarttrost Dok via Spotify her: https://podcasters.spotify.com/pod/show/svarttrost/subscribe eller ved å trykke på abonner-knappen i Apple Podkaster.    «IS-søstrene» er laget av Kari Hesthamar. Lyddesign ved Nils Jakob Langvik. Ansvarlig redaktør i Svarttrost er Kari Hesthamar. Serien har fått støtte av Fritt Ord, og er fra 2024.  

These new disinfectant wipes from MicroCare check many of the boxes in daily practice for infection control. KOLs shared their feedback. Annie Walters, MS, RDH This article is sponsored by MicroCare: https://www.rdhmag.com/sponsored/article/55055870/microcare-medical-spec-clean-disinfectant-wipes-elevating-the-standard-of-disinfection?o_eid=&oly_enc_id=&rdx.ident[pull]=omeda|&utm_campaign=CPS240605066&utm_medium=email&utm_source=RDH+eVillage+%26+Product

Sign up for free on Eden - https://ooo.joineden.ai/signup Mint the episode here - https://pods.media/ooopodcast/marketing-for-defi-and-what-product-experimentation-you-need-to-get-to-100m-tvl Hello everyone, This week's guest is Akanshu Jain (aka Kakusan), Co-founder of Brahma.fi Kaku has a strong track record of driving growth across various sectors. He has led growth for Iflix, which was later acquired by Tencent. In 2017, Kaku and his team launched a fintech app focused on Bitcoin and credit cards. By 2019, they built a crypto fund for institutions, scaling it to $100 million. In 2020, they turned their focus to DeFi, founding BrahmaFi to tackle execution and UX challenges in DeFi. Taking it a notch further, Brahma Console was initiated to streamline on-chain interactions in a fully non-custodial way. a TL;DR * Their product strategy and how that impacted their marketing decisions * Their point farming campaign, Karma rewards, how they run and they aim with it * The challenges in pushing Brahma.fi as an integrated smart account * Pre-TGE strategy to build up the hype for ultimate Token launch * Their user-acquisition strategy, from sourcing right KOLs to pushing right messaing * Upcoming marketing strategies they plan to experiment with the Accelerate On-Chain campaign and more. Support the show here https://linktr.ee/supporttheooo Get in touch: Kaku - https://x.com/jainargh Brahma - https://www.brahma.fi/ Follow us: Twitter ⁠⁠https://twitter.com/ooo_podcast⁠⁠ LinkedIn -⁠ ⁠https://www.linkedin.com/company/ooo-podcast/ ⁠⁠ Farcaster - ⁠h⁠ttps://warpcast.com/frogule⁠⁠ Alexandra - ⁠⁠https://twitter.com/frogule⁠⁠ Alex LinkedIn - ⁠⁠https://www.linkedin.com/in/alexandranicorici/⁠ Chapters 00:00 Introduction and Background 02:47 Shift in Product Strategy 06:19 Product-Led Marketing 17:5 Accelerate on Chain Campaign 25:58 Referral Program and Token Launch 33:01 Marketing to Retail and Power Users 36:55 Finding the Balance Between Product and Marketing 41:12 Experimenting with Landing Page and Content 44:19 Partnering with Protocols in Hype Cycles 55:04 Building Novel Products on Console 58:53 Using revoke.cash for Permission Management

My guests this week are Vandana Grover, Sr Director, Head of Digital Strategy and Innovation at Eisai and Stevan Tomich, Lead Omni Channel Strategist at AbbVie who discuss the value of social listening for MSL success.    This episode is sponsored by medical.watch. Medical.watch helps you understand what HCPs are saying about your products and diseases on social media. Free sign up at medical dot watch.   Learn….  How successful MSLs are going about social listening  What social channels are most viable right now and where should MSLs be “listening  What is the structure (for lack of a better word) an MSL could follow for social listening  What types of key insights might an MSL learn about their KOLs through social listening How social listening can play a part in conference preparation and strategy   The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.     MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.   #msl #medicalaffairs #medicalscienceliaison #msltalk #sociallistening

关注公众号【Albert英语研习社】，0元报名《周一到周六 英语思维风暴营》直播大课，Albert带你巧用英语思维，轻松突破听说读写译。 "Neo-Chinese style," a mixture of classical attire and everyday clothes has become the latest fashion trend in China. The boom is backed by young people's growing confidence in and attachment to their country.The New Chinese Style has been steadily gaining steam in China for the way in which it so effortlessly cuts through the noise of Western aesthetics and pop culture. It has pushed e-commerce platforms to double down on their efforts to showcase collaborations between brands and KOLs wearing such looks.主播：周邦琴Albert●没有名牌大学背景，没有英语专业背景●没有国外留学经历，没有英语生活环境●22岁成为500强公司全球员工英文讲师●24岁自学成为同声传译●25岁为瑞士联邦总统翻译

The full title for this session was 'The Digital Opinion Leader: Are We in Medical at Risk of Losing the Human Connection?' For this webinar we collaborated with CREATION.co, experts in HCP Social Media Listening and Identifying and Activating Digital Opinion Leaders. In this episode: -Learn about the influence of DOLs, the importance of staying current with rapidly changing opinions, and the impact of DOLs on traditional KOLs. -Gain practical tips on leveraging social media for better real-life conversations. -Discover how a recognised DOL is reshaping medical engagement. Join Helen Kane, One MSL CEO and Daniel Ghinn, CREATION.co CEO to dive into this valuable topic. One MSL & CREATION.co https://www.onemsl.com/ https://creation.co/

Devon is one of the best Marketeers of the Web3 era. He'll share frameworks & strategies from his time at Ava Labs, Immutable & F/AS that can help any Web3 project grow. Do not miss this!...Marketing is everything from understanding the market, the competition, establishing digital and physical channels, finding your voice, amplifying your community, and enabling them to amplify your work as much as you do...In this 'Masterclass', Devon will share his experience working with some of the biggest and most successful Blockchain projects, including:- What does Web3 marketing comprise- The art of storytelling and building a narrative- How to communicate across different media types- How to harness a Web3 community for growth- The importance (or not) of 'KOLs'- Which 'narratives' in 2024 are hot, or just hot air...If you're working in growth, marketing, or leadership for a Web3 project, you NEED to hear what Devon has to say.

A PubMed search on the day this was written finds 36,735 new publications in the last 24 hours. Adding the word “oncology” narrows the number to 4,334. Substituting “lung cancer” for “oncology” results in 534 articles. How many of these do you think your HCPs and KOLs will be able to read before the next batch of publications comes out tomorrow? This is to say that publishing a scientific study or article can feel like squeezing an eyedropper into the ocean and it is the job of the publication's team to ensure this drop-in-the-ocean has impact — especially when publishing a study with the potential to change clinical practice. Here we learn practical tips straight from the source – namely, experts at Wiley. How can you translate peer-reviewed publications to clinical impact? How can licensing extend (or perhaps restrict…) the reach of published research? How can publications be leveraged as the hub of an omnichannel approach? Listen to learn more.

In this episode, Liz and Rachel discuss how to coach KOLs to prevent information overload by discussing John Sweller's Cognitive Load Theory. Tune in for their tips on managing the intrinsic load of the content while improving the germane load through presenting the information with existing schema. Finally, learn how to reduce the extraneous load which may distract from the learning. Related Resources:Cognitive Load Theory: A Teacher's Guide by Structural Learning Connect with us on LinkedIn:   ⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Liz Cumby⁠⁠⁠⁠⁠⁠ About Cumby Consulting:   Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

What makes a top live commerce host or KOL (Key Opinion Leader)? Is it their appearance, emotional intelligence, talent, or training? Or are these just the bare minimum requirements? Our team visited the top three Multi-Channel Networks (MCNs) in China last week (as part of our MW Immersion: Live Commerce), uncovering the secrets behind their success in such a competitive landscape. With millions of aspiring KOLs, how does one truly stand out and become the best of the best? Tune in as we dive into what MCNs are doing to nurture talent, as well as the innovative business strategies they are exploring to grow without over-relying on KOLs.  This episode also distills eight key learnings from our immersion, touching on diverse topics from the rise of AI hosts and sustained platform investments to leveraging China's robust supply chain for live commerce.  Featured materials:  MW Immersions: Live Commerce [Hangzhou, May 2024], Momentum Works  Who is Temu?, Momentum Works  Is MCN a good business model?, The Impulso Podcast Our learnings from visiting top MCNs in China, The Impulso Podcast

This is a terrific and informative episode with Amanda Proscia as our Guru. Amanda helps us through many aspects of a med tech launch especially with the use of story telling as a best practice. Amanda provides guidance on how to use story telling techniques with investors, KOLs and customers! You will love the ideas and techniques Amanda Brings in this episode!

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence. On today's episode, Julia Steele Rodriguez is joining us to talk about Key Opinion Leader (KOL) programs and their indispensable role in healthcare marketing. Julia is an industry leader with a background leading diverse teams in marketing, operations, revenue cycle, and clinical education, and she's bringing us her insights on the impacts that KOL partnerships can have on health marketing strategies. Our conversation focuses on the fundamental aspects of building and sustaining effective KOL programs. We explore best practices for identifying the right KOLs, fostering long-term and mutually beneficial relationships, and the critical nuances often overlooked in these partnerships. Julia also offers her insights into the marketing advantages of robust KOL programs, spotlighting how they can transform healthcare initiatives and enhance brand trust. In addition, Julia shares her perspective on handling common challenges in KOL relationships, the importance of clear communication, and how to measure the success of such programs using the right KPIs. Her holistic approach and emphasis on human connections provide valuable lessons for anyone looking to leverage KOLs to drive healthcare marketing success. Thank you for being part of the Health Marketing Collective, where strong leadership meets marketing excellence. The future of healthcare depends on it. Key Takeaways: 1. Clear Definitions and Expectations: Julia emphasized the importance of having a shared understanding of what constitutes a KOL within the organization. This clarity helps align objectives and ensures that everyone involved is on the same page. It's vital to have a mutual understanding with KOLs themselves to foster an effective and productive relationship from the start. 2. Strategic Identification and Engagement: Identifying the right KOLs involves a mix of objective data and subjective measures. Julia suggests looking at publications, conference participation, and leadership roles in professional societies. Additionally, engaging with KOLs in their natural environments, such as conferences, can provide deeper insights into their fit and potential for partnership. 3. Fostering Long-Term Relationships: Building long-term relationships with KOLs requires mutual benefit and respect. Julia notes that understanding what KOLs want to gain from the partnership, beyond financial compensation, is crucial. Many KOLs seek to influence market developments and innovation, and providing them with insider insights and involvement opportunities can strengthen the relationship. 4. Internal Alignment and Communication: Internal consistency in dealing with KOLs, from contracting to invoicing to regular updates, is critical to maintaining smooth and effective collaborations. Missteps in these areas can lead to frustration and disengagement. Julia highlighted the importance of trust and proactive communication to keep KOLs engaged and valued. 5. Measuring Success: Success in KOL programs isn't just about immediate ROI but also about long-term impacts on healthcare outcomes and organizational credibility. Julia points to anecdotal evidence, changes in market sentiment, share of voice in industry conversations, and the overall influence KOLs bring to marketing strategies and product adoption as key indicators of a program's effectiveness. [embed]https://youtu.be/1Xgck3OwH1o?si=02POoGJz5aI6A3Va[/embed]

In this informative episode of The Negotiation podcast, host Todd Embley is joined by Olivia Plotnick, the founder of Wai Social and a renowned expert in China marketing.  Since her last appearance on the podcast in 2020, the landscape of digital consumption in China has evolved significantly, and Olivia is here to shed light on the latest trends and platforms shaping the Chinese market. Olivia kicks off the discussion by updating listeners on the shifts in consumer behavior and the emergence of new marketing platforms. The conversation zooms in on Xiaohongshu, a platform that, while hugely popular in China, remains relatively unknown to many Western audiences. Olivia explains what Xiaohongshu is, detailing its features, interface, user base, and its unique position in the social media landscape. She discusses the impact of Xiaohongshu on users' lives, particularly how it influences shopping behaviors and lifestyle choices. Olivia provides valuable insights into how brands are successfully leveraging Xiaohongshu, offering practical tips for marketers looking to engage with this platform. She also clarifies the difference between Key Opinion Leaders (KOLs) and Key Opinion Consumers (KOCs), and discusses which product categories thrive on Xiaohongshu. Highlighting recent successful campaigns, Olivia points out innovative strategies that brands have employed on Xiaohongshu. She also explores current lifestyle trends that are gaining traction on the platform, like "Citywalk," and their broader implications for consumer engagement. Lastly, Olivia addresses the buzz around the 6/18 shopping festival, providing her perspective on whether these large-scale promotional events still resonate with consumers in a rapidly changing retail environment. Discussion Points:Updates on China's digital consumption landscape since 2020.An in-depth look at Xiaohongshu: features, user base, and market position.The influence of Xiaohongshu on consumer behavior and lifestyle.Effective strategies for brands using Xiaohongshu and tips for new entrants.The distinction between KOLs and KOCs on social platforms.Product categories that are well-suited for marketing on Xiaohongshu.Analysis of recent standout brand campaigns on Xiaohongshu.Emerging lifestyle trends on Xiaohongshu and their impact on marketing.The relevance of shopping festivals like 6/18 in today's consumer market.

Get your free Dealfront demo here: ⁠⁠⁠https://bit.ly/49CrzqW⁠⁠⁠ Collect the full episode here - https://bit.ly/4bpPGtJ ⁠Hello everyone, This week's guest is Krystyna Kozak-Kornacka, CMO  @Cookie3_com . Krystyna leads Cookie3 Communications, Marketing, and Community, where she develops unique strategies to transform marketing in the Web3 space and open doors for everyone to participate in the MarketingFi economy. Drawing from her extensive experience as a communications and marketing expert, she excels in reaching diverse audiences and creating impactful campaigns. a TLDR * How is Cookie3 different now than 3 months ago * Their rebranding process and why was it necessary * Their community growth strategy * Best practices in taking the best out of Cookie3 now * KOLs and their role in the upcoming bull market * Case studies and more. Support the show here https://linktr.ee/supporttheooo Get in touch: Krystyna - https://x.com/KrysiaKozak Cookie3 - https://www.cookie3.com/ Follow us: Twitter https://twitter.com/ooo_podcast LinkedIn - https://www.linkedin.com/company/ooo-podcast/ Farcaster - https://warpcast.com/frogule Alexandra - https://twitter.com/frogule Alex LinkedIn - https://www.linkedin.com/in/alexandranicorici/ #web3marketing #web3podcast #cookie3 #womeninweb3 #web3startup #web3marketingpodcast #marketinginweb3

In our final Industry 101 episode we explore the vital role of Key Opinion Leaders (KOLs) in shaping industry trends, innovations, and healthcare practices. In this podcast we delve deep into the qualities industry is looking for in a KOL, why they are important, how to resolve conflicts when they arise, and what early investigators can do now to position themselves to become KOLS. Whether you're a healthcare professional, industry insider, or simply curious about the inner workings of the pharmaceutical world, you'll want to tune in to gain actionable insights, and a deeper understanding of the pivotal role KOLs play in driving progress and innovation in the field.

We have an outstanding Guru in this episode. Mr. Ron Richard, author, innovator consultant & musician is with us. Ron is the founder of BLD Medical Consulting. We get into a wide-ranging conversation discussing how music and math is so closely related and how music can spark innovation. We get into how he and his teams developed 40+ new devices that have generated over $1 Billion is revenue and helped countless clinicians and patients. We touch on why you the Med Tech innovator need to think differently about how you reach KOLs, communicate, educate and sell! Ron offers such a wealth of knowledge based on experience and terrific outcomes he has seen. You will love this episode!

In this week's episode Tom shares his journey as a commercial leader taking healthtech companies from seed stage to multi billion dollar listings on the NYSE! We discussed:

Behind every orthodontic innovation, there's a story waiting to be told. And today, we're lucky to hear from Dr. Vas Srinivasan and the fascinating story behind the inception and development of Spark Aligners.Dr. Vas Srinivasan is an orthodontist with a rich background. Born in India with a passion for quality higher education, he moved to the United States and eventually settled in Australia, where he established his practice.Without his input, Spark Clear Aligners wouldn't exist. He played a huge role by being part of the initial trial group in the early stages of development. He was the only doctor who documented and presented cases and paperwork that helped the team refine the product and eventually get the necessary approvals.  He shares some of the behind-the-scenes experiences encountered during the development phase of Spark aligners and the collaborative efforts that drive innovation in our field.Additionally, we discuss the role of KOLs and the responsibilities and impact of these thought leaders in vetting and disseminating new technologies and methodologies.Dr. Srinivasan also shares a deeply personal aspect of his life: his transformative weight loss journey including the approach he used to improve his health.Tune in to the full episode to hear Dr. Srinivasan's story and incredible insights on innovation in orthodontics and life.Key TakeawaysIntro (00:00)Dr. Srinivasan's background story (02:37)Inspiration to move to Australia (05:11)Journey of personal health and weight loss (11:57)Mental and physical benefits of yoga (18:35)The origin story of Spark Aligners (27:39)Comparison of aligner brands (36:29)The significance of KOLs in orthodontics (41:37)Importance of being more than just an orthodontist (46:07)Additional ResourcesConnect with Dr. Vas Srinivasan:- Website: https://www.invisibleorthodontics.com.au/- Instagram: https://www.instagram.com/vassrinivasan—-- Register for the OrthoPreneurs Summit at Sea (2024): https://opsummitatsea.com/- For more information, visit: https://orthopreneurs.com/- Join our FREE Facebook group here: https://www.facebook.com/groups/OrthoPreneurs

In this week's episode, Sara shares her journey of working with the NHS and healthcare clients over the last 20 years. Whilst also staying + building a career at one SINGLE company (Deloitte)!  We discussed:

As part of the importer series, Yi Xin Ong, Managing Partner of KOT Selections in Singapore, provides an international perspective. From Singapore's 2-3,000 active importers for the small island to the impact of international media, Yi Xin describes how KOT navigates the importing, distributing, and retailing of its portfolio of winegrowers.  Detailed Show Notes: Background Founded KOT in 2011 - they couldn't get the wines they were buying in Singapore, three partnersWork w/ 57 winegrowers, mainly in Europe, 6 in the USSingapore wine market (~6M population, ~20% Muslim - don't drink)No 3-tier system, no gov't monopolyIt is a pretty open market, like the UKMany players are vertically integrated - import, distribute, retail - with lots of captive distributors and retailersVery low barriers to entry - founded KOT in 2 months for S$200 to get licensing and paperworkHorizontally spread - ~2-3,000 active importers (in 2011, ~700 importers, mainly focused on Australia/NZ with either big brands or high-scoring wines)Two casinos / integrated resorts provided the spark for other wines (e.g., Marina Bay Sands opened in 2011)Generally, 1-1.5 generations behind the UK and US wine marketsTook inspiration from other importers - Kermit Lynch (CA), Louis / Dressner (NY), Yapp Brothers (UK Rhone Specialists) - importing wines others were notYapp - focused on winegrowersDressner - spent a lot of wine visiting growers, good storytellingKermit Lynch - newsletters (1970s) were key to storytelling for the wine growersStorytelling is critical to standing out in a crowded marketSourcing strategy - most wineries they bought from personally (90%) were not represented in SingaporeInformal rule - 5 visits to winegrowers between the three partners before they importBroad portfolios - easier to serve clients and fulfill their needsFocused portfolios - clearer story and differentiationOptimal portfolio size - ~50-70 to give each winegrower ~1 week/year of focusKOT differentiationMarket knowledgeLinks to trade, client baseTrust of the people (have only signed one contract, mainly handshake deals, exclusive relationships) -> been burnt occasionally with generational changeBuild brands in Singapore - a very organic approachGet the right people to taste them - professionals, and influencers / Key Opinion Leaders (“KOL”)Host tastings every year, even for highly allocated wines (e.g., Pierre Gonon)KOLs can drive demandInt'l media have a strong influence - English is the primary languageMore important than local mediaOnly the top few have an impact - The Wine Advocate (Robert Parker), Jancis Robinson (less emphasis on scores, more on editorial content)Robert Parker had a big impact on the local market; a Singaporean bought the company100-point scores can drive sales spikesConsumer data/reviews can start trends, increasingly importantVivino, Wine-Searcher, CellarTracker, Instagram75% wholesale, 25% direct-to-consumer sales (mainly e-commerce)Private clients saw KOT through the pandemicTrade is vital for tourist demandSingaporean wine trendsNew regions increasing, Japanese and Chinese winesValue increasing - ~$20-30 retail, ~$5-10 FOBThe low/no alcohol trend is not a thing yetRose has never been a trend Get access to library episodes Hosted on Acast. See acast.com/privacy for more information.

What does it take to succeed in a competitive orthodontic market? My guest this week has firsthand experience and lessons that any doctor will find valuable.I had the privilege of interviewing Dr. Chad Foster, a highly respected orthodontist known for his clinical excellence, business acumen, and refreshing candor. He practices in Phoenix, AZ, and is the Editor of Orthotown.At the heart of our discussion is the role of embracing uncomfortable situations. Dr. Foster shares his personal experience of starting a practice in a competitive market, the initial doubts that plagued him, and how confronting these fears head-on led to unexpected growth and success.We also highlight the importance of feedback, critique, and continuous learning in achieving clinical excellence and professional fulfillment.We also talk about the impact of social media platforms on both professional and personal lives. While some of the platforms provide a unique opportunity to learn, share cases, and get feedback, they can also expose the less savory side of people.Tune in this episode for this and more with Dr. Chad Foster!Key TakeawaysIntro (00:00)Growing an orthodontic practice in a competitive market (01:30)Uncomfortable conversations in dentistry (05:17)Maintaining passion in orthodontics over time (09:52)Balancing clinical orthodontics with business management (14:08)The role of KOLs in the orthodontics (18:32)How Chad got involved with Orthotown and became the Editor (27:34)Social media, self-care, and parenting (36:14)Resilience and gratitude in our profession (43:11)Additional Resources- Orthotown website: https://www.orthotown.com/- Register for the OrthoPreneurs Summit at Sea (2024): https://opsummitatsea.com/- For more information, visit: https://orthopreneurs.com/- Join our FREE Facebook group here: https://www.facebook.com/groups/OrthoPreneurs

Receive your weekly UGC Video alert - Totally Free => https://hubs.ly/Q02qJN4H0Special guest Carmen Muley is a livestreaming pioneer. She is CEO at FREIM Studio, which is everything livestreaming and live shopping. From strategy to training, to production and execution as well as sourcing, training and management of KOLs. She is also the Founder and CEO at Izzy Agency. Her background is in live and social commerce for brands, eCommerce companies and digital marketing agencies that want to learn about the latest trends and strategies.Hear perspectives on the latest rumors about live shopping. Learn about Carmen's experience as a host in China for the first ever AliExpress 11/11 (Single's Day) shopping festival for Spain and LATAM back in 2016. Discover why marketing is vital to the success of a live shopping event. Find out the differences between livestreaming in China, UK, the US, and Latin markets. Get tips on setting expectations for sales and results from a live event. Gain an understanding of how to select an effective host. Uncover Carmen's three steps for success to get results and get encouragement if you're feeling hesitant about doing shopping events.About eStreamly: eStreamly enables shoppable livestreams & videos across platforms, including your website, social media, SMS, emails... Video become a direct ecommerce extension with in-video checkout, boasting a 10-15% conversion rate. Fast and reliable, it's your payment, your inventory, your ecommerce.

In this week's episode, Meri shares his journey from the world of investing to breaking the bottlenecks in clinical trials as he builds the anti-CRO for life science pioneers.  We discussed: 

Laura Liotta is the President of Sam Brown Inc. Healthcare Communications, which she founded in 1999. She is an accomplished, healthcare public relations and corporate communications executive with 35 years of experience supporting all sectors of the healthcare industry: life sciences, pharmaceuticals, biotechnology, medical device, venture firms, healthcare services, patient, advocacy, and nonprofit organizations. Sam Brown Inc. is fiercely independent, mid-size agency with deep expertise and experience helping a wide range of early- to late-stage biotechnology and pharmaceutical clients communicate their value through all phases of development and direct to patients. The agency has helped numerous public and private company tell their story creatively and strategically through analytics, public and media relations, outstanding creative services, and digital and social media within the life sciences space. Day to day, Laura is focused on Sam Brown agency management, business development and ensuring outstanding client service. She is an experienced communications strategist and a trusted advisor to C-suite executives and board members. She has a seat at the table for strategic planning, messaging and counsel. In her long career, Laura has worked on significant corporate events such as company launches, financial raises, IPOs, deals and acquisitions, and exits, while also facing numerous business and clinical issues facing the biotech and pharmaceutical industries. Laura is an experienced and well-respected media and presentation trainer to a variety of spokespeople, including CEOs and executive leadership teams, Board members, Scientists, KOLs, Advocacy, Celebrities and Patients. At Sam Brown, training and messaging is seen as an critical extension of the corporate and brand strategy and not delegated to an external trainer. She has a deep understanding of the pharmaceutical and SEC regulatory environment and need for guardrails. Laura has successfully trained thousands of people for broadcast, print and online interviews, plus podcasts.  Laura started her public relations and public affairs career at DuPont Merck, Nexell Therapeutics and Smithkline Beecham. She is a graduate of Rowan University with a BA in Communications with Public Relations specialty. She lives in Villanova, Pennsylvania, is most proud of her 3 children and the Sam Brown team. More of Laura: Website: sambrown.com LinkedIn: linkedin.com/in/lauraliotta/ Facebook: @sambrowninc Twitter (X): @sambrowninc